A discrete-choice experiment study of physicians’ prioritization of attributes of medical treatments for endometriosis-associated pain
article
OA: hybrid
CC0
AI-generated summary
Obstetrician-gynecologists prioritized avoiding moderate-to-severe hot flashes over pain reduction and other risks when choosing treatments for endometriosis-associated pain.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BACKGROUND: Physicians' preferences for attributes of medical treatments for endometriosis-associated pain have not previously been quantified. METHODS: US obstetrician-gynecologists completed an online discrete-choice experiment survey. In a series of questions, physicians chose a medical treatment for a hypothetical patient with endometriosis experiencing severe, persistent dysmenorrhea, nonmenstrual pelvic pain, and/or dyspareunia. Each question presented two hypothetical medical treatments for endometriosis-associated pain, defined by seven attributes with varying levels. Preferences weights and conditional relative importance (CRI) were calculated using a random-parameters logit model. RESULTS: Respondents (N = 250) had an average age of 53 years; 36% were female. The most important attribute, conditional on the attributes and levels evaluated, was risk of moderate-to-severe hot flashes (CRI, 3.34). In descending order of importance, the CRIs of the other attributes were 2.13 for improvement in nonmenstrual pelvic pain, 2.04 for improvement in dyspareunia, 1.88 for improvement in dysmenorrhea, 1.16 for risk of pregnancy-related complications if pregnancy occurs during treatment, 0.62 for increased risk of bone fracture later in life, and 0.48 for mode of administration. CONCLUSIONS: In addition to valuing pain reduction, respondents prioritized avoiding moderate-to-severe hot flashes, followed by less common and less immediate risks of pregnancy-related complications and bone fracture.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (20)
- EPIDEMIOLOGY OF ENDOMETRIOSIS via openalex
- Patient preferences for elagolix and leuprolide for treating endometriosis-related pain in the United States via openalex
- Patient Preferences for Endometriosis Pain Treatments in the United States via openalex
- Prevalence and Symptomatic Burden of Diagnosed Endometriosis in the United States: National Estimates from a Cross-Sectional Survey of 59,411 Women via openalex
- Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist via openalex
- W2048709304 via openalex
- W2069365179 via openalex
- W2121619367 via openalex
- W2159936838 via openalex
- W2317442454 via openalex
- W2367707061 via openalex
- W2616708772 via openalex
- W2895773179 via openalex
- W4234160457 via openalex
- W1532743717 via openalex
- W4252978187 via openalex
- W1590210216 via openalex
- W1950747970 via openalex
- W1994077204 via openalex
- W2032869670 via openalex
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-20T00:34:22.421210+00:00
License: CC0
· commercial use OK